Publication | Closed Access
73 POSTER Pharmacokinetic characterization of BIBF 1120, an orally active triple angiokinase inhibitor (VEGFR, PDGFR, FGFR) in advanced cancer patients
17
Citations
0
References
2006
Year
Poster Pharmacokinetic CharacterizationMedicineAdvanced Cancer PatientsPharmacologyPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyCancer ResearchBibf 1120
No additional data available for this publication yet. Check back later!